MDG1.STU MEDIGENE N (MDG1.SG)
- Market cap
- -
- P/E
- -
- P/B
- 1.53x
- ROE
- -83.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2024.
Is MDG1.STU undervalued?
Graham numberThe Graham number of MEDIGENE N (MDG1.SG) cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
MEDIGENE N (MDG1.SG) fundamental analysis
No fundamental analysis for MEDIGENE N (MDG1.SG) yet.
MEDIGENE N (MDG1.SG) stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
MEDIGENE N (MDG1.SG) financial statements
2024 annualized: Fiscal year 2024 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2024, the balance sheet is the latest quarter. Figures change when the annual report is published.
MEDIGENE N (MDG1.SG) annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 4.89M | 7.80M | 7.58M | 10.5M | 8.00M | 10.5M | 31.2M | 6.03M | 5.83M |
| Gross Profit | 3.49M | 6.18M | 1.28M | 10.1M | 6.71M | 9.10M | 29.3M | 4.39M | 4.50M |
| Operating Income | -15.6M | -14.5M | -17.8M | -20.2M | -23.3M | -9.99M | -8.73M | -16.1M | -16.4M |
| EBITDA | - | -10.5M | -15.3M | -17.1M | -21.5M | -6.49M | 13.1M | -14.6M | - |
| Net Income | -9.49M | -13.6M | -17.0M | -20.0M | -28.9M | -9.98M | -8.33M | -16.2M | -16.3M |
| EPS | - | -0.61 | -0.69 | -0.81 | -2.23 | -0.77 | -0.64 | -1.25 | -1.11 |
| Balance Sheet | |||||||||
| Total Assets | 112M | 112M | 130M | 109M | 74.8M | 59.5M | 51.7M | 31.7M | 28.8M |
| Total Liabilities | 33.1M | 25.8M | 22.2M | 27.4M | 21.6M | 14.7M | 14.7M | 10.6M | 9.15M |
| Shareholders' Equity | 78.6M | 86.2M | 107M | 81.8M | 53.2M | 44.8M | 37.0M | 21.1M | 19.7M |
| Cash & Short-term Investments | 14.6M | 27.7M | 27.4M | 34.7M | 30.0M | 22.4M | 22.2M | 8.67M | 14.0M |
| Cash Flow | |||||||||
| Operating Cash Flow | -3.76M | -20.8M | -10.1M | -16.4M | -24.8M | -10.8M | 12.0M | -15.1M | - |
| Capital Expenditure | 1.72M | 1.56M | 1.01M | 1.43M | 484K | 125K | 1.01M | 664K | 0.00 |
| Free Cash Flow | - | -22.4M | -11.2M | -17.9M | -25.3M | -10.9M | 11.0M | -15.8M | - |
| Ratios | |||||||||
| ROE | -12.1% | -15.8% | -15.9% | -24.4% | -54.3% | -22.3% | -22.5% | -76.8% | -83.0% |
| ROA | -8.5% | -12.1% | -13.2% | -18.3% | -38.6% | -16.8% | -16.1% | -51.0% | -56.7% |
| Net Profit Margin | -194.1% | -174.0% | -225.0% | -189.9% | -360.8% | -95.4% | -26.7% | -268.1% | -280.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
MEDIGENE N (MDG1.SG) dividends
MEDIGENE N (MDG1.SG) has not paid dividends in the last 8 fiscal years.
Last stock split: 1:2 on Aug 29, 2024.
Who owns MEDIGENE N (MDG1.SG)
Ownership data of MEDIGENE N (MDG1.SG) is not available yet.
MEDIGENE N (MDG1.SG) company profile
- Company name
- MEDIGENE N (MDG1.SG)
- Ticker
- MDG1.STU
- ISIN
- DE000A1X3W00
- Exchange
- Stuttgart Exchange
- Sector
- Other
- Industry
- Metals & Mining
- Fiscal year end
- December
- Address
- Website
- -
About MEDIGENE N (MDG1.SG)
There is no Profile data available for MDG1.SG.